The congress gathers more than a thousand poultry specialists from around the world and presents an excellent opportunity to build and develop profitable exchanges and relationships.

Ceva will share its latest innovations and expert knowledge in poultry vaccination, equipment and services. The Ceva stand will provide practical and technical information to help poultry producers to improve their performance using new technology products such as Transmune®, Vectormune® ND and Egginject®.

One hot topic sure to be discussed at the congress is the subject of avian influenza (AI). The disease has proved to be a major threat for the global poultry industry, disrupting international trade and inducing heavy economical losses in infected flocks.

Nevertheless, there is still a debate raging about the necessity of AI vaccination.

In that context, during the congress, Ceva will hold a symposium with leading global figures, including the USDA, to address the current AI situation and discuss the differing industry perspectives.

The symposium will be entitled: “Avian Influenza – The value of vaccination in changing times”.

Indeed, Ceva’s vector vaccine Vectormune® AI offers a new way to control this disease in vaccinating countries around the world.

To find out more visit: www.ceva.com or www.avian-influenza-vaccines.com.